Catalyst Wire Dossier Catalyst Wire Dossier

Veoza

fezolinetant · Astellas Pharma Europe B.V.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Veoza, covering 2026-04-21 to 2026-08-21. Get the full timeline:

Most recent: EMA Authorised: Veoza (fezolinetant) — Astellas Pharma Europe B.V.

See pricing